Clinical and economical cost-utility evaluation in the treatment of patients with coronary artery disease;Klinische und okonomische kosten-nutzen-relation bei der behandlung von patienten mit koronarer herzerkrankung

Zeitschrift fur Kardiologie

Volumn 87, Issue SUPPL. 2, 1998, Pages 8-19

  Hoher M ^a   Hombach, V ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Coronary artery disease; Cost effectiveness analysis; Primary prevention; Rehabilitation; Stent implantation

Indexed keywords

ACUTE HEART INFARCTION; ANGINA PECTORIS; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; QUALITY OF LIFE; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; COST BENEFIT ANALYSIS; ECONOMICS; GERMANY; HEART INFARCTION; PATIENT CARE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; COST-BENEFIT ANALYSIS; GERMANY; HUMANS; MYOCARDIAL INFARCTION; PATIENT CARE TEAM; STENTS;

EID: 0031786668     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Ades PA, Huang D, Weaver SO ( 1992) Cardiac rehabilitation participation predicts lower rehospitalization costs. Am Heart J 123: 916-921
2. Bjarnson-Wehrens B, Predel HG, Graf C, Rost R (1997) Das Kölner Modell der ambulanten kardialen Rehabilitation. Herz Kreisl 29: 224-231
3. Breyer F, Zweifel P (1997) Gesundheitsökonomie. Springer Verlag, Berlin Heidelberg
4. Cohen DJ, Breall JA, Ho KK, Kuntz RE, Goldman L, Baim DS, Weinstein MC (1994) Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation 89: 1859-1874
5. Dennis C, Houston Miller N, Schwartz RG, Ahn DK, Kraemer HC, Gossard D, Juneau M, Taylor CB, DeBusk RF (1988) Early return to work after uncomplicated myocardial infarction. Results of a randomized trial. JAMA 260: 214-220
6. Drummond MF, Stoddard GL, Torrance GW (1987) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford
7. Eisenberg JM (1989) Clinical economics. A guide to the economic analysis of clinical practices. JAMA 262: 2879-2886
8. Eissenhauer W, Grunenwald H, Oeser E (1988) Anschlussheilbehandlung, was bringt das? Eine statistische Betrachtung. Rehabilitation 27: 18-21
9. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331: 496-501
10. Goldman L (1990) Cost-effectiveness perspectives in coronary heart disease. Am Heart J 119: 733-739
11. Hedback B, Perk J, Wodlin P (1993) Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programme. Eur Heart J 14: 831-835
12. Jonsson B, Johannesson M, Kjekshus J, Olsson AG, Pedersen TR, Wedel H (1996) Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S). Eur Heart J 17: 1001-1007
13. Koopmanschap MA, van Ineveld BM (1992) Towards a new approach for estimating indirect costs of disease. Soc Sci Med 34: 1005-1010
14. Kübler W, Niebauer J, Kreuzer J (1994) Kosten/Nutzen-Relation: Bewertung der stationären und ambulanten Rehabilitation. Z Kardiol 83 (Suppl 6): 151-158
15. Kupersmith J, Holmes Rovner M, Hogan A, Rovner D, Gardiner J (1994) Cost-effectiveness analysis in heart disease, Part I: General principles. Prog Cardiovasc Dis 37: 161-184
16. Kupersmith J, Holmes Rovner M, Hogan A, Rovner D, Gardiner J (1995) Cost-effectiveness analysis in heart disease, Part II: Preventive therapies. Prog Cardiovasc Dis 37: 243-271
17. Kupersmith J, Holmes Rovner M, Hogan A, Rovner D, Gardiner J ( 1995) Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias. Prog Cardiovasc Dis 37: 307-346
18. Levin LA, Perk J, Hedback B (1991) Cardiac rehabilitation - a cost analysis. J Intern Med 230: 427-434
19. Multiple Risk Factor Intervention Trial Research Group (1982) Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 248: 1465-1477
20. Niebauer J, Hambrecht R, Marburger C, Schlierf G, Kubler W, Schuler G (1994) Fettarme Diät und körperliches Training bei koronarer Herzkrankheit. Langzeitergebnisse der Sekundärprävention. Dtsch Med Wochenschr 119: 7-12
21. Oldridge N, Furlong W, Feeny D, Torrance G, Guyatt G, Crowe J, Jones N (1993) Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol 72: 154-161
22. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA (1988) Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 260: 945-950
23. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331: 489-495
24. Taylor R, Kirby B (1997) The evidence base for the cost effectiveness of cardiac rehabilitation. Heart 78: 5-6
25. Torrance GW (1987) Utility approach to measuring health-related quality of life. J Chronic Dis 40: 593-603
26. Weinstein MC, Stason WB (1977) Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296: 716-721